LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
99.91
-3.14 (-3.05%)
At close: Feb 27, 2025, 4:00 PM
90.00
-9.91 (-9.92%)
After-hours: Feb 27, 2025, 4:30 PM EST
LeMaitre Vascular Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LeMaitre Vascular stock have an average target of 93.14, with a low estimate of 75 and a high estimate of 100. The average target predicts a decrease of -6.78% from the current stock price of 99.91.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LeMaitre Vascular stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Initiates $95 | Hold | Initiates | $95 | -4.91% | Feb 13, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $90 → $93 | Buy | Reiterates | $90 → $93 | -6.92% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $92 → $93 | Buy | Maintains | $92 → $93 | -6.92% | Nov 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Initiates $96 | Hold | Initiates | $96 | -3.91% | Oct 15, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $92 | Buy | Maintains | $92 | -7.92% | Sep 20, 2024 |
Financial Forecast
Revenue This Year
224.52M
from 193.48M
Increased by 16.04%
Revenue Next Year
246.06M
from 224.52M
Increased by 9.59%
EPS This Year
1.98
from 1.34
Increased by 47.98%
EPS Next Year
2.21
from 1.98
Increased by 11.57%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 232.1M | 258.4M | 286.0M | |||
| Avg | 224.5M | 246.1M | 266.3M | |||
| Low | 214.6M | 232.3M | 248.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 19.9% | 15.1% | 16.2% | |||
| Avg | 16.0% | 9.6% | 8.2% | |||
| Low | 10.9% | 3.4% | 0.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 2.07 | 2.48 | 2.68 | |
| Avg | 1.98 | 2.21 | 2.44 | |
| Low | 1.88 | 2.02 | 2.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 54.4% | 25.0% | 21.0% | |
| Avg | 48.0% | 11.6% | 10.1% | |
| Low | 40.4% | 1.8% | 1.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.